Sunzen Group (0148) Fair Value & Analysis
Consumer Defensive · MY · Market cap 180M MYR
Fair value as of: Jun 24, 2026
Analysis
Sunzen Group (0148) currently trades at 0.2300 MYR, while our model-based Fair Value estimate is 0.1200 MYR — implying the stock looks roughly 47.8% overvalued today. We read business quality at 80/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells traditional Chinese medicine; trades in crude palm oil and derivative products; and manufactures, imports, trades in, exports, and sells bird's nests and related products. In addition, the company retails herbal drinks, foodstuffs, hampers, and related health products. Further, it engages in the wholesale and trading of animal health and nutrition products for livestock, animal beauty, and cosmetic products; and retail, wholesale, distribution, and tra…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Sunzen Group (0148) undervalued?
What is the fair value of 0148?
What is the quality score of 0148?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.